Tue, Sep 16, 2014, 4:01 AM EDT - U.S. Markets open in 5 hrs 29 mins

Recent

% | $
Quotes you view appear here for quick access.

ADVANCED CELL TECH Message Board

  • lastbullstanding lastbullstanding May 2, 2013 12:53 PM Flag

    in reading some ARVO abstracts of upcoming conference

    one of the most interesting to me......at least in RPE methods....was the cell sheet (fabricated Bruch) that was delivered with a novel method....basically that did eight rabbits but were able to deliver the sheets without the more invasive surgery ....which was the argument on why our method was better than the fabricated Bruch...the deliver it into the subretinal by a custum made plunger

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Is their delivery "old" or less effective? Or are you pointing out we are using a better delivery that leaves them behind us, thus a non-competitor?

      • 1 Reply to demetergreen
      • They are able to delivery virtually the same as us....using a needle or a "cannula".....and a custum made plunger....I'm assuming that the plunger was sent through the cannula.......If you are interested in this stuff.....go read some abstracts they are easy enough to find.....basically when we used to have thoughtful discussion around here....the consenses was that the procedure to lay a sheet of cells in was more invasive yet this method is pretty close to our method ....other than on a sheet ....and IPS of course

        Here is the conclusion to this particular study:"We presented a novel device to transplant hiPSC-RPE cells-sheet safely and stably with the correct positioning into subretinal space by inserting the grafts in the coaxial direction of flow paths and with adequate subretinal drainage. We will further confirm these results by transplanting hiPSC-RPE cell-sheet into monkey eyes."

 
ACTC
0.08150.0000(0.00%)Aug 27 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Avanir Pharmaceuticals, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT
JDS Uniphase Corporation
NasdaqGSMon, Sep 15, 2014 4:15 PM EDT